Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

Autor: von Groote-Bidlingmaier, Florian, Patientia, Ramonde, Sanchez, Epifanio, Balanag, Vincent, Jr, Ticona, Eduardo, Segura, Patricia, Cadena, Elizabeth, Yu, Charles, Cirule, Andra, Lizarbe, Victor, Davidaviciene, Edita, Domente, Liliana, Variava, Ebrahim, Caoili, Janice, Danilovits, Manfrid, Bielskiene, Virgaine, Staples, Suzanne, Hittel, Norbert, Petersen, Carolyn, Wells, Charles, Hafkin, Jeffrey, Geiter, Lawrence J, Gupta, Rajesh
Zdroj: In The Lancet Respiratory Medicine March 2019 7(3):249-259
Databáze: ScienceDirect